What is the recommended treatment for streptococcal pharyngitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Streptococcal Pharyngitis

For patients with confirmed streptococcal pharyngitis, penicillin or amoxicillin is the recommended first-line treatment due to their proven efficacy, safety, narrow spectrum of activity, and low cost. 1

First-Line Treatment Options

For Patients Without Penicillin Allergy:

  • Oral Penicillin V:

    • Children: 250 mg two or three times daily for 10 days
    • Adolescents and adults: 250 mg four times daily or 500 mg twice daily for 10 days
    • (Strong recommendation, high-quality evidence) 1
  • Oral Amoxicillin:

    • 50 mg/kg once daily (maximum = 1,000 mg) for 10 days
    • Alternative: 25 mg/kg twice daily (maximum = 500 mg) for 10 days
    • (Strong recommendation, high-quality evidence) 1
    • Note: Amoxicillin is often preferred for young children due to better taste acceptance 1
  • Intramuscular Benzathine Penicillin G (single dose):

    • < 60 lb (27 kg): 600,000 U
    • ≥ 60 lb: 1,200,000 U
    • (Strong recommendation, high-quality evidence) 1
    • Particularly useful for patients with anticipated poor adherence to oral therapy 1

For Patients With Penicillin Allergy:

  • First-generation Cephalosporins (if not anaphylactically sensitive):

    • Cephalexin: 20 mg/kg twice daily (maximum = 500 mg per dose) for 10 days
    • Cefadroxil: 30 mg/kg once daily (maximum = 1 g) for 10 days
    • (Strong recommendation, high-quality evidence) 1
  • Clindamycin:

    • 7 mg/kg three times daily (maximum = 300 mg per dose) for 10 days
    • (Strong recommendation, moderate-quality evidence) 1
  • Macrolides (note: resistance concerns exist):

    • Azithromycin: 12 mg/kg once daily (maximum = 500 mg) for 5 days
    • Clarithromycin: 7.5 mg/kg twice daily (maximum = 250 mg per dose) for 10 days
    • (Strong recommendation, moderate-quality evidence) 1, 2

Adjunctive Therapy

  • Analgesics/antipyretics (acetaminophen, NSAIDs) may be used for symptom relief and fever control 1
  • Aspirin should be avoided in children due to risk of Reye syndrome 1
  • Corticosteroids are not recommended 1

Special Considerations

Chronic Carriers

For patients with recurrent episodes of pharyngitis with positive Group A Streptococcus (GAS) tests who may be chronic carriers, antibiotics are generally not recommended unless:

  1. Community outbreak of acute rheumatic fever or invasive GAS infection
  2. Outbreak in a closed community
  3. Personal/family history of acute rheumatic fever
  4. Excessive anxiety about GAS infections
  5. Tonsillectomy being considered solely for carrier state 1

For chronic carriers requiring treatment, recommended regimens include:

  • Clindamycin (20-30 mg/kg/day in 3 doses for 10 days)
  • Amoxicillin-clavulanate (40 mg/kg/day in 3 doses for 10 days) 1

Follow-up Recommendations

  • Routine post-treatment testing is not recommended for asymptomatic patients 1
  • Testing of asymptomatic household contacts is not routinely recommended 1

Common Pitfalls to Avoid

  1. Inadequate treatment duration: The full 10-day course of penicillin or amoxicillin must be completed to prevent rheumatic fever, even if symptoms resolve earlier 1

  2. Inappropriate use of macrolides: Due to increasing resistance, macrolides should be reserved for patients with true penicillin allergy 1

  3. Twice-daily dosing considerations: While twice-daily dosing of penicillin V (500 mg) is as effective as more frequent dosing, once-daily dosing of penicillin is associated with decreased efficacy and should not be used 3

  4. Failure to distinguish carriers from acute infection: Patients with recurrent positive tests may be carriers experiencing viral infections rather than recurrent streptococcal infections 1

  5. Overtreatment of viral pharyngitis: Testing is not recommended when clinical features strongly suggest viral etiology (cough, rhinorrhea, hoarseness, oral ulcers) 1

By following these evidence-based guidelines, clinicians can effectively treat streptococcal pharyngitis while minimizing complications, reducing antimicrobial resistance, and improving patient outcomes.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.